| Market Capitalization (Millions $) |
3 |
| Shares
Outstanding (Millions) |
16 |
| Employees |
4 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Accustem Sciences Inc is a company that specializes in the development and commercialization of innovative diagnostics and therapies for cancer patients. Their focus is on personalized medicine, using genetic information to tailor treatments to individual patients.
The company utilizes advanced technologies to analyze genomic and proteomic data, providing insights into disease mechanisms and treatment options. They also offer prognostic and diagnostic tests to aid in the early detection and monitoring of cancer.
Accustem Sciences Inc aims to improve patient outcomes by providing physicians with targeted therapies that have a higher likelihood of success. Their research and development efforts are focused on identifying new drug targets and developing companion diagnostics to optimize treatment efficacy.
The company collaborates with academic institutions, pharmaceutical companies, and healthcare organizations to further its research and expand its product portfolio. Their ultimate goal is to make personalized medicine accessible to a wider population, ultimately improving the quality of care for cancer patients.
Company Address: 420 Lexington Avenue NY 10001 NY
Company Phone Number: 2074952379 Stock Exchange / Ticker: ACUT
|
0.06%